HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.

Total
0
Shares
Related Posts